NeuBase Therapeutics, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NeuBase Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2020-09-30 was $0.00.
- NeuBase Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2020-06-30 was $0.00.
- NeuBase Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2020-03-31 was $0.00.
- NeuBase Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- NeuBase Therapeutics, Inc. payments for repurchase of common stock for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- NeuBase Therapeutics, Inc. payments for repurchase of common stock for fiscal 2019 was $14.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | $0.00 10-K · filed 2020-12-23 |
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | $0.00 derived: sum of 4 quarters · filed 2020-12-23 |
| 2020-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | $0.00 derived: sum of 4 quarters · filed 2020-12-23 |
| 2019-12-31 | $0.00 10-Q · filed 2020-03-26 | $0.00 derived: sum of 4 quarters · filed 2020-12-23 |
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | $14.00 10-K · filed 2020-12-23 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | |
| 2018-12-31 | $14.00 10-Q · filed 2020-03-26 |